Insiders InnoCan Pharma Corporation

Equities

Delayed Canadian Securities Exchange Other stock markets 03:39:30 2026-03-10 pm EDT			5-day change	1st Jan Change
6.580 ^CAD	0.00%		+7.87%	-1.79%

Feb. 27	InnoCan Pharma Corporation Receives Third Consecutive FDA CVM Fee Waiver For LPT-CBD Product	CI
Feb. 09	InnoCan Pharma Says Latest LPT-CBD Trial Involving Dogs Published in Peer-Reviewed Journal	MT

25-07-03	Chair of Innocan Pharma Resigns	MT
25-07-03	InnoCan Pharma Corporation Announces Executive Changes, Effective July 1, 2025	CI
23-09-15	InnoCan Pharma Corporation Announces Appointment of Dr. Joseph V. Pergolizzi to its Scientific Advisory Board	CI
22-11-18	Innocan Pharma Corporation Announces the Addition of Givi Topchishvili, to Advisory Committee, as A Business Strategy Adviser	CI
22-08-11	InnoCan Pharma Corporation Appoints Roni Kamhi as Chief Operating Officer	CI
22-02-07	Innocan Pharma Corporation Announces Appointment of Dr. Kenji Kitatani to Advisory Committee	CI
21-07-14	Iinnocan Pharma Corporation Announces Addition of Izhar Shay to its Advisory Committee	CI
21-04-06	Innocan Pharma Corporation Appoints Richard Serbin to its Advisory Committee	CI
21-03-23	InnoCan Pharma Corporation Appoints Mitchell Kline to Its Scientific Advisory Committee	CI
20-07-02	Innocan Pharma Corporation Announces Resignation of Bill Macdonald as Member of Board of Directors	CI
20-01-23	InnoCan Pharma Corporation Adds Peter Bloch to Its Board of Directors	CI